Cargando…
Treatment of Nephrogenic Diabetes Insipidus Patients With cGMP-Stimulating Drugs Does Not Mitigate Polyuria or Increase Urinary Concentrating Ability
Autores principales: | Hinrichs, Gitte R., Mortensen, Line A., Bistrup, Claus, Dieperink, Hans H., Jensen, Boye L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403538/ https://www.ncbi.nlm.nih.gov/pubmed/32775834 http://dx.doi.org/10.1016/j.ekir.2020.05.015 |
Ejemplares similares
-
A Novel AQP2 Sequence Variant Causing Aquaporin-2 Retention in the Cytoplasm and Autosomal Dominant Nephrogenic Diabetes Insipidus
por: Hinrichs, Gitte R., et al.
Publicado: (2022) -
A novel mutation affecting the arginine‐137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin‐2
por: Hinrichs, Gitte R., et al.
Publicado: (2016) -
Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice
por: Procino, Giuseppe, et al.
Publicado: (2014) -
Amiloride resolves resistant edema and hypertension in a patient with nephrotic syndrome; a case report
por: Hinrichs, Gitte R., et al.
Publicado: (2018) -
Lithium induces microcysts and polyuria in adolescent rat kidney independent of cyclooxygenase‐2
por: Kjaersgaard, Gitte, et al.
Publicado: (2014)